You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: December 4, 2023

CLINICAL TRIALS PROFILE FOR MEXATE-AQ

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Mexate-aq

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002798 ↗	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome	Completed	National Cancer Institute (NCI)	Phase 3	1996-08-01	Randomized phase III trial to compare the effectiveness of different chemotherapy regimens with or without bone marrow transplantation in treating children who have acute myelogenous leukemia or myelodysplastic syndrome. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. It is not yet known which treatment regimen is more effective for acute myelogenous leukemia or myelodysplastic syndrome
NCT00002970 ↗	506U78 in Treating Patients With Refractory Hematologic Cancer	Completed	Children's Cancer Group	Phase 2	1997-06-01	Phase II trial to study the effectiveness of 506U78 in treating patients with recurrent or refractory hematologic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
NCT00002970 ↗	506U78 in Treating Patients With Refractory Hematologic Cancer	Completed	National Cancer Institute (NCI)	Phase 2	1997-06-01	Phase II trial to study the effectiveness of 506U78 in treating patients with recurrent or refractory hematologic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Mexate-aq

Condition Name

Chart
Table

Condition Name for Mexate-aq
Intervention	Trials
Acute Lymphoblastic Leukemia	26
Untreated Adult Acute Lymphoblastic Leukemia	17
Leukemia	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Mexate-aq
Intervention	Trials
Leukemia	83
Leukemia, Lymphoid	71
Precursor Cell Lymphoblastic Leukemia-Lymphoma	71
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Mexate-aq

Trials by Country

Map
Table

Trials by Country for Mexate-aq
Location	Trials
Canada	171
Australia	73
New Zealand	25
Puerto Rico	18
Japan	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Mexate-aq
Location	Trials
Texas	64
Washington	53
Ohio	52
California	52
Pennsylvania	47
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Mexate-aq

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Mexate-aq
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	31
Phase 2/Phase 3	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Mexate-aq
Clinical Trial Phase	Trials
Completed	52
Active, not recruiting	30
Recruiting	25
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mexate-aq

Sponsor Name

Chart
Table

Sponsor Name for Mexate-aq
Sponsor	Trials
National Cancer Institute (NCI)	108
Children's Oncology Group	25
M.D. Anderson Cancer Center	24
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Mexate-aq
Sponsor	Trials
NIH	117
Other	111
Industry	29
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Merck

McKesson

Mallinckrodt

Medtronic

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.